Related Experiment Video
Updated: Apr 28, 2026
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
Machine Learning Identification of Metabolism-Related Biomarkers with Diagnostic Potential for Gastric Cancer:
Weihao Kong1,2, Jiawen Wang1, Kangjie Zhang2
1Department of Emergency Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.
Background:
An increasing body of evidence suggests an association between metabolic syndrome and gastric cancer. However, the shared genetic signatures and underlying molecular mechanisms between them remain to be elucidated.
Methods:
We obtained transcriptomic data for gastric cancer and metabolic syndrome from the GEO, TCGA, and GTEx databases. Using the Limma and WGCNA algorithms respectively, we identified differential genes and co-expression module genes related to metabolic syndrome and gastric cancer. Lasso and SVM were employed to further screen for hub genes, while XGBoost was utilized to enhance the diagnostic value of these hub genes. CIBERSORT and GSVA were applied to assess the correlation among hub genes for immune infiltration and metabolic scores. Single-cell and spatial transcriptomic analyses were conducted to explore cell subpopulations and tissue distribution of hub genes in gastric cancer. We used qPCR experiments to detect expression differences of hub genes between gastric cancer tissues and normal tissues.
Results:
CSE1L, IL32, and CCDC86 were identified as shared hub genes between metabolic syndrome and gastric cancer. These genes were significantly associated with immune cell infiltration and dysregulated metabolic pathways. Single-cell analysis revealed elevated glycolysis across gastric cancer cell subpopulations, accompanied by enhanced cell-cell interactions. Spatial transcriptomic analysis confirmed the upregulation of hub genes in tumor regions. qPCR further verified significantly higher mRNA expression levels of these genes in gastric cancer tissues than in adjacent normal tissues.
Conclusion:
CSE1L, IL32, and CCDC86 may represent potential metabolism-related biomarkers associated with gastric cancer and metabolic syndrome. These findings provide additional insight into the molecular links between the two conditions and may support future mechanistic studies and larger-scale clinical validation.
